Cite
HARVARD Citation
Rachid, O. et al. (2020). CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes. Expert opinion on investigational drugs. pp. 221-236. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rachid, O. et al. (2020). CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes. Expert opinion on investigational drugs. pp. 221-236. [Online].